Cargando…
Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States
BACKGROUND: Resection is the cornerstone of curative treatment for many nonmetastatic gastric cancers (GCs), but the population treatment patterns remains largely unknown. This large international population‐based study aimed at investigating the treatment patterns and trends for nonmetastatic GC in...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586997/ https://www.ncbi.nlm.nih.gov/pubmed/33135354 http://dx.doi.org/10.1002/ctm2.203 |
_version_ | 1783600102729842688 |
---|---|
author | Huang, Lei Jansen, Lina Balavarca, Yesilda Verhoeven, Rob H.A. Ruurda, Jelle P. Van Eycken, Liesbet De Schutter, Harlinde Johansson, Jan Lindblad, Mats Johannesen, Tom B. Zadnik, Vesna Žagar, Tina Mägi, Margit Bastiaannet, Esther Lagarde, Sjoerd M. van de Velde, Cornelis J.H. Schrotz‐King, Petra Brenner, Hermann |
author_facet | Huang, Lei Jansen, Lina Balavarca, Yesilda Verhoeven, Rob H.A. Ruurda, Jelle P. Van Eycken, Liesbet De Schutter, Harlinde Johansson, Jan Lindblad, Mats Johannesen, Tom B. Zadnik, Vesna Žagar, Tina Mägi, Margit Bastiaannet, Esther Lagarde, Sjoerd M. van de Velde, Cornelis J.H. Schrotz‐King, Petra Brenner, Hermann |
author_sort | Huang, Lei |
collection | PubMed |
description | BACKGROUND: Resection is the cornerstone of curative treatment for many nonmetastatic gastric cancers (GCs), but the population treatment patterns remains largely unknown. This large international population‐based study aimed at investigating the treatment patterns and trends for nonmetastatic GC in Europe and the United States and at exploring factors associated with resection. METHODS: Data of patients with microscopically confirmed primary invasive GC without distant metastasis from the national cancer registries of the Netherlands, Belgium, Sweden, Norway, Slovenia, and Estonia and the US Surveillance, Epidemiology, and End Results (SEER)‐18 Program were retrieved. Age‐standardized treatment rates were computed and trends were evaluated using linear regression. Associations of resection with patient and tumor characteristics were analyzed using multivariable‐adjusted log‐binomial regression. Analysis was performed in each country respectively without pooling. RESULTS: Together 65 707 nonmetastatic GC patients diagnosed in 2003‐2016 were analyzed. Age‐standardized resection rates significantly decreased over years in all countries (by 4‐24%). In 2013‐2014, rates varied greatly from 54 to 75%. Patients with increasing ages, cardia cancers, or cancers invading adjacent structure were significantly less frequently resected. Resection was further associated with sex, performance status, comorbidities, tumor histology, tumor size, hospital type, and hospital volume. Association patterns and strengths varied across countries. After multivariable adjustment, resection rates remained decreasing (prevalence ratio = 0.97‐0.995 per year), with decreasing trends consistently seen in various subgroups. CONCLUSIONS: In Europe and the United States, nonmetastatic gastric cancers were less frequently resected in the early 21st century. Resection rates varied greatly across countries and appeared not optimal. Various factors associated with resection were revealed. Our findings identify differences and possibly modifiable places in clinical practice and provide important novel references for designing effective population‐based management strategies. |
format | Online Article Text |
id | pubmed-7586997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75869972020-10-30 Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States Huang, Lei Jansen, Lina Balavarca, Yesilda Verhoeven, Rob H.A. Ruurda, Jelle P. Van Eycken, Liesbet De Schutter, Harlinde Johansson, Jan Lindblad, Mats Johannesen, Tom B. Zadnik, Vesna Žagar, Tina Mägi, Margit Bastiaannet, Esther Lagarde, Sjoerd M. van de Velde, Cornelis J.H. Schrotz‐King, Petra Brenner, Hermann Clin Transl Med Research Articles BACKGROUND: Resection is the cornerstone of curative treatment for many nonmetastatic gastric cancers (GCs), but the population treatment patterns remains largely unknown. This large international population‐based study aimed at investigating the treatment patterns and trends for nonmetastatic GC in Europe and the United States and at exploring factors associated with resection. METHODS: Data of patients with microscopically confirmed primary invasive GC without distant metastasis from the national cancer registries of the Netherlands, Belgium, Sweden, Norway, Slovenia, and Estonia and the US Surveillance, Epidemiology, and End Results (SEER)‐18 Program were retrieved. Age‐standardized treatment rates were computed and trends were evaluated using linear regression. Associations of resection with patient and tumor characteristics were analyzed using multivariable‐adjusted log‐binomial regression. Analysis was performed in each country respectively without pooling. RESULTS: Together 65 707 nonmetastatic GC patients diagnosed in 2003‐2016 were analyzed. Age‐standardized resection rates significantly decreased over years in all countries (by 4‐24%). In 2013‐2014, rates varied greatly from 54 to 75%. Patients with increasing ages, cardia cancers, or cancers invading adjacent structure were significantly less frequently resected. Resection was further associated with sex, performance status, comorbidities, tumor histology, tumor size, hospital type, and hospital volume. Association patterns and strengths varied across countries. After multivariable adjustment, resection rates remained decreasing (prevalence ratio = 0.97‐0.995 per year), with decreasing trends consistently seen in various subgroups. CONCLUSIONS: In Europe and the United States, nonmetastatic gastric cancers were less frequently resected in the early 21st century. Resection rates varied greatly across countries and appeared not optimal. Various factors associated with resection were revealed. Our findings identify differences and possibly modifiable places in clinical practice and provide important novel references for designing effective population‐based management strategies. John Wiley and Sons Inc. 2020-10-08 /pmc/articles/PMC7586997/ /pubmed/33135354 http://dx.doi.org/10.1002/ctm2.203 Text en © 2020 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Huang, Lei Jansen, Lina Balavarca, Yesilda Verhoeven, Rob H.A. Ruurda, Jelle P. Van Eycken, Liesbet De Schutter, Harlinde Johansson, Jan Lindblad, Mats Johannesen, Tom B. Zadnik, Vesna Žagar, Tina Mägi, Margit Bastiaannet, Esther Lagarde, Sjoerd M. van de Velde, Cornelis J.H. Schrotz‐King, Petra Brenner, Hermann Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States |
title | Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States |
title_full | Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States |
title_fullStr | Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States |
title_full_unstemmed | Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States |
title_short | Decreasing resection rates for nonmetastatic gastric cancer in Europe and the United States |
title_sort | decreasing resection rates for nonmetastatic gastric cancer in europe and the united states |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586997/ https://www.ncbi.nlm.nih.gov/pubmed/33135354 http://dx.doi.org/10.1002/ctm2.203 |
work_keys_str_mv | AT huanglei decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT jansenlina decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT balavarcayesilda decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT verhoevenrobha decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT ruurdajellep decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT vaneyckenliesbet decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT deschutterharlinde decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT johanssonjan decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT lindbladmats decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT johannesentomb decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT zadnikvesna decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT zagartina decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT magimargit decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT bastiaannetesther decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT lagardesjoerdm decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT vandeveldecornelisjh decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT schrotzkingpetra decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates AT brennerhermann decreasingresectionratesfornonmetastaticgastriccancerineuropeandtheunitedstates |